Randomised controlled clinical trial to determine the efficacy of saindhava sanyukta dashmool ghrita nasya in management of ardhavabhedaka with special reference to common migraine.

Randomised controlled clinical trial to determine the efficacy of Saindhava Sanyukta Dashmool Ghrita Nasya in management of Ardhavabhedaka with special reference to Common Migraine. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090405

Enrollment

Registered

2025-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G00-G99- Diseases of the nervous system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients whose informed written consent has been taken. 2. Patients between age group 18 to 60 years (Male and Female). 3. Patients fulfilling the diagnostic symptoms such as unilateral headache, nausea ,vomiting , vertigo of Ardhavbhedaka will be selected randomly irrespective of age, sex, religion and occupation. 4. Patients fit for Nasya karma.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from Shiroroga like Sooryavarta. 2.Systemic disorders such as DM, HTN, etc which will affect or interfere course of treatment. 3.Patients contraindicate for Nasya karma. 4.Secondary headache caused due to meningitis, encephalitis, cervical spondylosis. 5.Referred pain due to diseases of eye, ear, nose, teeth etc. 6.Patients with complicated migraine that is complications like loss of hearing, loss of vision.

Design outcomes

Primary

Measure	Time frame
Improvement in MigraineTimepoint: 21 Days	—

Secondary

Measure	Time frame
Decrease in Symptoms of Migraine.Timepoint: 21 Days	—

Countries

India

Contacts

Public ContactDr Anil Deshmukh

SSTAC Sangamner

ranwaraanil@gmail.com9822262627

Outcome results